BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26266381)

  • 1. Recurrence Risk Factors Analysis for Stage I Non-small Cell Lung Cancer.
    Wu CF; Fu JY; Yeh CJ; Liu YH; Hsieh MJ; Wu YC; Wu CY; Tsai YH; Chou WC
    Medicine (Baltimore); 2015 Aug; 94(32):e1337. PubMed ID: 26266381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The prognostic impact of preoperative PET-CT on postoperative recurrence for completely resected stage I non-small cell lung cancer].
    Qiang G; Xu R; Liu J; Yan J; Xu Y; Di J; Da J; Liang C; Shi B; Guo Y; Liu D
    Zhonghua Wai Ke Za Zhi; 2015 Jul; 53(7):502-7. PubMed ID: 26359072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of metastatic N1 lymph node ratio and angiolymphatic invasion in patients with pathologic stage IIA non-small cell lung cancer.
    Wu CF; Wu CY; Fu JY; Wang CW; Liu YH; Hsieh MJ; Wu YC
    Medicine (Baltimore); 2014 Oct; 93(20):e102. PubMed ID: 25365403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for Local and Distant Recurrence After Surgical Treatment in Patients With Non-Small-Cell Lung Cancer.
    Dziedzic DA; Rudzinski P; Langfort R; Orlowski T;
    Clin Lung Cancer; 2016 Sep; 17(5):e157-e167. PubMed ID: 26831834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis After Sublobar Resection of Small-sized Non-small Cell Lung Cancer with Visceral Pleural or Lymphovascular Invasion.
    Moon Y; Lee KY; Park JK
    World J Surg; 2017 Nov; 41(11):2769-2777. PubMed ID: 28597091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in Predicting Recurrence After Resection of Node-Negative Non-Small Cell Lung Cancer.
    Thornblade LW; Mulligan MS; Odem-Davis K; Hwang B; Waworuntu RL; Wolff EM; Kessler L; Wood DE; Farjah F
    Ann Thorac Surg; 2018 Nov; 106(5):1460-1467. PubMed ID: 30031845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomograms for Predicting Overall and Recurrence-free Survival From Pathologic Stage IA and IB Lung Cancer After Lobectomy.
    Merritt RE; Abdel-Rasoul M; Fitzgerald M; D'Souza DM; Kneuertz PJ
    Clin Lung Cancer; 2021 Jul; 22(4):e574-e583. PubMed ID: 33234491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of pleural recurrence after percutaneous transthoracic needle biopsy in stage I non-small-cell lung cancer.
    Ahn SY; Yoon SH; Yang BR; Kim YT; Park CM; Goo JM
    Eur Radiol; 2019 Jan; 29(1):270-278. PubMed ID: 29948086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological vascular invasion and tumor differentiation predict cancer recurrence in stage IA non-small-cell lung cancer after complete surgical resection.
    Shimada Y; Saji H; Yoshida K; Kakihana M; Honda H; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    J Thorac Oncol; 2012 Aug; 7(8):1263-70. PubMed ID: 22673056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for lymph node negative stage I and IIA non-small cell lung cancer: multicenter experiences.
    Oven Ustaalioglu BB; Unal OU; Turan N; Bilici A; Kaya S; Eren T; Ulas A; Inal A; Berk V; Demirci U; Alici S; Bal O; Benekli M; Gumus M
    Asian Pac J Cancer Prev; 2013; 14(11):6287-92. PubMed ID: 24377519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphovascular space invasion and tumor differentiation are predictors for postoperative recurrence in patients with pathological stage I nonsmall cell lung cancer.
    Chen YY; Huang TW; Tsai WC; Lin LF; Cheng JB; Lee SC; Chang H
    J Chin Med Assoc; 2014 Aug; 77(8):416-21. PubMed ID: 25028298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence.
    Harpole DH; Herndon JE; Young WG; Wolfe WG; Sabiston DC
    Cancer; 1995 Sep; 76(5):787-96. PubMed ID: 8625181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for tumor recurrence in patients with early-stage (stage I and II) non-small cell lung cancer: patient selection criteria for adjuvant chemotherapy according to the seventh edition TNM classification.
    Maeda R; Yoshida J; Ishii G; Hishida T; Nishimura M; Nagai K
    Chest; 2011 Dec; 140(6):1494-1502. PubMed ID: 21622548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgeons' preference sublobar resection for stage I NSCLC less than 3 cm.
    Huang CS; Hsu PK; Chen CK; Yeh YC; Hsu HS; Shih CC; Huang BS
    Thorac Cancer; 2020 Apr; 11(4):907-917. PubMed ID: 32037690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of Web-Based Nomograms to Precisely Predict Conditional Risk of Site-Specific Recurrence for Patients With Completely Resected Non-small Cell Lung Cancer: A Multiinstitutional Study.
    Zhang Y; Zheng D; Xie J; Li Y; Wang Y; Li C; Xiang J; Zhang Y; Hu H; Sun Y; Chen H
    Chest; 2018 Sep; 154(3):501-511. PubMed ID: 29758181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing recurrence following anatomic lung resection for clinical stage I non-small cell lung cancer.
    Schuchert MJ; Normolle DP; Awais O; Pennathur A; Wilson DO; Luketich JD; Landreneau RJ
    Lung Cancer; 2019 Feb; 128():145-151. PubMed ID: 30642447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of clinical T4 stage superior sulcus non-small cell lung cancer: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
    Wen J; Liu D; Chen D; Chen J; Xu X; Chen C; Zhang F; Duan S; Zhu R; Fan M; Chen Y
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30647107
    [No Abstract]   [Full Text] [Related]  

  • 19. Prediction of distant recurrence in resected stage I and II lung adenocarcinoma.
    Aramini B; Casali C; Stefani A; Bettelli S; Wagner S; Sangale Z; Hughes E; Lanchbury JS; Maiorana A; Morandi U
    Lung Cancer; 2016 Nov; 101():82-87. PubMed ID: 27794412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics associated with the use of nonanatomic resections among Medicare patients undergoing resections of early-stage lung cancer.
    Kim AW; Detterbeck FC; Boffa DJ; Decker RH; Soulos PR; Cramer LD; Gross CP
    Ann Thorac Surg; 2012 Sep; 94(3):895-901. PubMed ID: 22835558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.